2020
DOI: 10.1177/0300060520971422
|View full text |Cite
|
Sign up to set email alerts
|

Effects of tacrolimus on autophagy protein LC3 in puromycin-damaged mouse podocytes

Abstract: Objective To investigate the mechanism through which tacrolimus, often used to treat refractory nephropathy, protects against puromycin-induced podocyte injury. Methods An in vitro model of puromycin-induced podocyte injury was established by dividing podocytes into three groups: controls, puromycin only (PAN group), and puromycin plus tacrolimus (FK506 group). Podocyte morphology, number, apoptosis rate and microtubule associated protein 1 light chain 3 alpha ( LC3) expression were compared. Results Puromycin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 26 publications
(32 reference statements)
0
4
0
Order By: Relevance
“…Tacrolimus minimizes renal tissue damage by inhibiting the expression of transient receptor potential cation channel-6 (TRPC6) and impeding T cell activation. Podocytes cultured independently in a 2D environment and subjected to puromycin-induced injury showed enhanced autophagy after tacrolimus treatment by increasing the expression of microtubule-associated proteins 1A/1B light chain 3A (LC3), thereby preventing renal damage [ 25 ]. In rodent models of PAN-induced podocyte injury, the administration of tacrolimus confirmed the restoration of podocyte foot processes.…”
Section: Discussionmentioning
confidence: 99%
“…Tacrolimus minimizes renal tissue damage by inhibiting the expression of transient receptor potential cation channel-6 (TRPC6) and impeding T cell activation. Podocytes cultured independently in a 2D environment and subjected to puromycin-induced injury showed enhanced autophagy after tacrolimus treatment by increasing the expression of microtubule-associated proteins 1A/1B light chain 3A (LC3), thereby preventing renal damage [ 25 ]. In rodent models of PAN-induced podocyte injury, the administration of tacrolimus confirmed the restoration of podocyte foot processes.…”
Section: Discussionmentioning
confidence: 99%
“…Xie and Yu ( 38 ) reported that the mitochondrial autophagy process mediated by the PINK1/Parkin signaling pathway is affected by a number of other proteins and related signaling pathways at the same time, so as to protect podocytes from external damage. Yang et al ( 39 ) revealed that by increasing the expression of autophagy-related protein LC3 and enhancing the autophagy activity of glomerular podocytes, they can significantly reduce the damage to glomerular podocytes in mice induced by puromycin, reduce the production of proteinuria and delay glomerular sclerosis. These findings suggest that increasing autophagy may be an effective protective mechanism of podocytes under the condition of injury.…”
Section: Discussionmentioning
confidence: 99%
“…TAC also enhanced the interaction of FKBP12 with actin-associated proteins 14-3-3β and synaptopodin to maintain F-actin [ 171 ]. Moreover, TAC significantly improved the expression of nephrin and podocin in diabetic rats [ 172 ] and maintained the microtubule-associated protein 1 light chain 3 alpha (LC3) expression in PAN-induced podocyte injury [ 173 ]. In clinical settings, CNIs were effective in FSGS [ 174 ] and lupus podocytopathy cases [ 175 ].…”
Section: Therapeutic Implicationsmentioning
confidence: 99%